Hirotetsu Takagi

Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway

Koji Ishida, Kosuke Kaji, Shinya Sato et al. · The Journal of Nutritional Biochemistry · 2020 · 87 citations · Full text

Life Sciences, Pharmacology, Toxicology +16

Thyroid‐stimulating hormone is an independent risk factor of non‐alcoholic fatty liver disease

Kazuki Tahara, Takemi Akahane, Tadashi Namisaki et al. · JGH Open · 2019 · 47 citations · Full text

Medicine, Endocrinology, Pathology +16

Indications for orthotopic liver transplantation: with particular reference to hepatomas, biliary atresia, cirrhosis, Wilson's disease and serum hepatitis.

TE Starzl, Graham G. Giles, Lilly et al. · PubMed · 1971 · 32 citations · Full text

Medicine, Pathology, Surgery +8

The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects

Hirotetsu Takagi, Kosuke Kaji, Norihisa Nishimura et al. · Cells · 2021 · 29 citations · Full text

Medicine, Oncology, Pharmacology +17

Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis

Hiroyuki Ogawa, Kosuke Kaji, Norihisa Nishimura et al. · Journal of Cellular and Molecular Medicine · 2021 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16